销售 更改
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
BioMarin Pharmaceutical USD 990M 224M 2026-06
Cipla INR 71.19B 5.78B 2026-06
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 6.35M 60.98M 2026-03
CSL USD 8.33B 4.79B 2025-12
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Grifols EUR 2B 306.7M 2026-03
Insmed USD 425.49M 119.53M 2026-06
OraSure Technologies USD 26.76M 322K 2025-12
Quidel USD 630.9M 10.9M 2026-06
Ultragenyx Pharmaceutical USD 214M 78M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06